Summary
This prediction ended on 16.05.17 with a price of €13.02. The prediction closed with a disappointing performance of 10.86%. mohabbatein has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evotec SE | -3.440% | -3.440% | -50.962% | -72.257% |
iShares Core DAX® | 0.051% | 5.593% | 14.403% | 19.767% |
iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% | 57.237% |
iShares Nikkei 225® | 2.181% | 2.815% | 11.116% | 8.873% |
iShares S&P 500 | 1.040% | 4.975% | 27.631% | 48.786% |
Comments by mohabbatein for this prediction
In the thread Evotec AG diskutieren
mohabbatein stimmt dem Sentiment von 'Sell' zu
mohabbatein stimmt am 10.05.2017 dem Sell-Gesamtsentiment mit dem Kursziel 8.5€ zu.
Die Zahlen waren sehr gut. Davon war auch auszugehen. Die Kurssteigerung der letzten Monate war mehr als beeindruckend. Mir fehlt die Fantasie für eine weitere Fortsetzung der Rallye nach einer Vervierfachung des Kurses. Da ich auch mit einem Rücksetzer der Märkte allgemein rechne, erscheint mir dieser Highflyer besonders korrekturanfällig. Reines Gefühl.
SELL.